I’ve written a lot about the loophole of therapeutic use exemptions (TUEs) that allows athletes to use performance-enhancing drugs such as anabolic steroids, growth hormone, amphetamines, etc. for a competitive advantage. I used the 2006 Tour de France as a prime example, where 60% of drug-tested riders had a TUE for some banned substance. The [...]